Govt eyes mobile policy, exports
Special Assistant to the Prime Minister, Haroon Akhtar Khan, conducted a Zoom meeting with Amir Allahwala, CEO of Transsion Techno, and representatives of the Engineering Development Board to discuss the Mobile Phone Device Policy.
According to a statement released on Friday, the meeting focused on key issues including the mobile phone device policy, challenges related to tariff duties, mobile phone exports, as well as the market for used cars and used mobile phones. The discussion also covered technological innovation.
As per the statement, Khan highlighted that 38 mobile phone companies in Pakistan have created 40,000 jobs, underscoring the significant potential of the mobile phone industry to export products globally.
He emphasised that under the directives of the prime minister, the government's priority is to promote the industrial sector. Incentivising the industry and increasing exports remain top priorities.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
2 days ago
- Business Recorder
EVs: 2 German firms keen to train technicians in Pakistan
ISLAMABAD: Two German tech companies have expressed serious interest in providing technical training to Pakistani firms and developing electric vehicles (EVs)-related infrastructure in the country. The development came during a meeting on EVs chaired by Special Assistant to the Prime Minister (SAPM) on Industries and Production Haroon Akhtar Khan with a special focus on EV skills training. The meeting was attended by representatives from the National Vocational and Technical Training Commission (NAVTTC), two German companies namely, Lucas Nülle and the Institute of Motor Industry (IMI) along with the officials from the Engineering Development Board (EDB). The agenda focused on the urgent need to develop skilled technicians for the growing electric vehicle industry in Pakistan. Discussions were held on the current gap in skills required for EV maintenance and services, and how to address these challenges through international collaborations and structured training programmes. Lucas Nülle and IMI expressed keen interest in partnering with NAVTTC to provide technical training in Pakistan aligned with international best practices. SAPM Haroon Akhtar Khan emphasised that Prime Minister Shehbaz Sharif envisions the successful implementation of Pakistan's electric vehicle policy, which requires a strong foundation of skilled human resources. He added that once electric vehicles become in mainstream on Pakistani roads, there will be a substantial demand for professionals trained in EV maintenance and battery services. 'The development of a skilled workforce in this sector will create widespread employment opportunities and contribute significantly to the national economy.' The SAPM further highlighted that all training models should be designed according to international standards to ensure global competitiveness. He termed trained EV technicians as a national asset. To move forward, Haroon Akhtar Khan directed the EDB and the Ministry of Industries and Production to work in close coordination with NAVTTC and the German companies to formulate a comprehensive training and implementation proposal. Copyright Business Recorder, 2025
Business Recorder
2 days ago
- Business Recorder
Meeting discusses forming Pak-Russia JVs in pharma sector
ISLAMABAD: Pakistan and Russia, Wednesday, discussed and reviewed bilateral relations in industrial cooperation especially starting on joint ventures in pharmaceutical sector. In this connection a meeting was held here under the chairmanship of Special Assistant to the Prime Minister (SAPM) on Industries and Production, Haroon Akhtar Khan, on insulin imports from Russia and joint ventures. The meeting was attended by Denis Nazarov, Representative of the Russian government, senior officials from the Ministry of Industries and Production, Ministry of National Health Services, and the Drug Regulatory Authority of Pakistan (DRAP). Discussions focused on the import of insulin from Russia, progress on pharmaceutical joint ventures, and the development of protocols for policy board implementation. The meeting was informed that the DRAP had earlier granted registration to Genetics Pharmaceuticals, Lahore, for the import of insulin from Russian company Zavod Medsintez. The meeting also discussed the matters related to the application of Eli Lilly's for an increase in maximum retail price (MRP). The officials informed the meeting that if the DRAP is considering the application of the insulin manufacturer, then it will become costlier than the insulin of Novo Nordisk Pharma, another European insulin maker. SAPM Haroon Akhtar Khan emphasised that the establishment of a pharmaceutical joint venture between Pakistan and Russia marks a significant milestone in strengthening bilateral relations. He noted that Pakistan is a major consumer of insulin, and the regular supply of insulin from Russia could greatly benefit diabetic patients across the country. He stated that in line with government's vision, efforts are under way to initiate local manufacturing of insulin in Pakistan. A joint protocol between local manufacturers and Russian companies is expected to be finalised and presented soon. Haroon Akhtar Khan directed all stakeholders to develop a comprehensive proposal prior to its presentation in the federal cabinet. Copyright Business Recorder, 2025
Express Tribune
2 days ago
- Express Tribune
In pharma JV, Pakistan to import Russian insulin
Listen to article Pakistan is set to import insulin from Russia with the help of joint ventures between pharmaceutical companies of the two countries. In that regard, a high-level meeting was held under the chairmanship of Special Assistant to Prime Minister (SAPM) on Industries Haroon Akhtar Khan. Russian government representative Denis Nazarov, senior officials of the Ministry of Industries and Production, Ministry of National Health Services and Drug Regulatory Authority of Pakistan (DRAP) were present in the huddle. Discussions focused on the purchase of insulin from Russia, progress on pharmaceutical joint ventures and the development of protocols for policy implementation. It was noted that DRAP had earlier granted permission to Genetics Pharmaceuticals, Lahore, for the import of insulin from Russian firm Zavod Medisintez. Haroon Akhtar emphasised that the establishment of a pharmaceutical joint venture between Pakistan and Russia marks a significant milestone in strengthening bilateral relations. He noted that Pakistan is a major consumer of insulin and its regular supply from Russia could greatly benefit diabetic patients across the country. He stated that in line with Prime Minister Shehbaz Sharif's vision, efforts are underway to initiate local manufacturing of insulin. In this connection, a joint protocol between local manufacturers and Russian companies is expected to be finalised soon. He directed all stakeholders to develop a comprehensive proposal. Sources revealed that a registration letter for the import of insulin from Zavod Medisintez was issued by DRAP on May 5, 2025 in favour of Genetics Pharmaceuticals. Subsequently, the company applied for an increase in the maximum retail price (MRP) on the basis of a rise in the Consumer Price Index (CPI), which is allowed under the Drug Pricing Policy, 2018. A revised MRP letter was issued to Genetics Pharmaceuticals on June 16, 2025. The manufacturer is demanding the MRP quoted by the originator brand of insulin, Eli Lilly. However, the importer has not so far submitted any application and justification for the increase in MRP. It is relevant to mention that leading local manufacturers, Getz Pharma and BF Bio Sciences, are selling locally manufactured insulin at MRPs equal to or lower than the MRP permitted for insulin import from Russia. If the MRP of Russian-manufactured insulin is increased, it will be higher compared to that of another European company, Novo Nordisk Pharma. The importer has two options to apply for increase in the MRP of insulin imported from Zavod Medisintez: an application may be submitted under the hardship category as per paragraph 9 of the Drug Pricing Policy, 2018 and the importer should submit evidence of import in commercial quantity from Russia. The MRP will be calculated on the basis of import price of the vaccine based on the value determined by Pakistan Customs on goods declaration under the Customs Act, 1969. The MRP will be based on the following formula: trade price = landed cost + 40% mark-up. The landed cost includes the import price converted into Pakistani rupees, customs duty, import levies and expenses. The MRP will be calculated by grossing up the trade price to provide for 15% retail discount. Hardship applications will be considered by the drug pricing committee and the MRP determined on the basis of above formula will be placed before the DRAP policy board. After endorsement by the board, the recommended MRP will be considered by a cabinet committee and its recommendation will be placed before the cabinet for approval.
